MR Imaging Techniques for Pancreas

Radiologic Clinics of North America

Volumn 50, Issue 3, 2012, Pages 379-393

  Tirkes, Temel ^a   Menias, Christine O ^b   Sandrasegaran, Kumaresan ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY   (United States)

Author keywords

Artifacts; Image optimization; Magnetic resonance cholangiopancreatography (MRCP); Magnetic resonance imaging; New MRI techniques; Pancreas; Secretin

Indexed keywords

CONTRAST MEDIUM; FERUMOXSIL; GADOLINIUM; SECRETIN;

ACUTE HEMORRHAGIC PANCREATITIS; CHRONIC PANCREATITIS; CLINICAL ASSESSMENT; CLINICAL EXAMINATION; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; DIFFUSION TENSOR IMAGING; DRUG CONTRAINDICATION; DRUG COST; DRUG DOSE REDUCTION; ELASTOGRAPHY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FAT CONTENT; HUMAN; IMAGE QUALITY; INTERMETHOD COMPARISON; MAGNETIC RESONANCE ANGIOGRAPHY; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS CYST; PANCREAS DISEASE; PRIORITY JOURNAL; REVIEW; SIGNAL NOISE RATIO; THREE DIMENSIONAL IMAGING;

CHOLANGIOPANCREATOGRAPHY, MAGNETIC RESONANCE; CONTRAST MEDIA; GADOLINIUM; HUMANS; IMAGE ENHANCEMENT; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE IMAGING; PANCREAS; PANCREATIC DISEASES; PANCREATIC NEOPLASMS;

EID: 84860578000     PISSN: 00338389     EISSN: 15578275     Source Type: Journal    
DOI: 10.1016/j.rcl.2012.03.003     Document Type: Review

References (51)

1. Coppens E., Metens T., Winant C., et al. Pineapple juice labeled with gadolinium: a convenient oral contrast for magnetic resonance cholangiopancreatography. Eur Radiol 2005, 15:2122-2129.
2. Papanikolaou N., Karantanas A., Maris T., et al. MR cholangiopancreatography before and after oral blueberry juice administration. J Comput Assist Tomogr 2000, 24:229-234.
3. Riordan R.D., Khonsari M., Jeffries J., et al. Pineapple juice as a negative oral contrast agent in magnetic resonance cholangiopancreatography: a preliminary evaluation. Br J Radiol 2004, 77:991-999.
4. Herborn C.U., Vogt F., Lauenstein T.C., et al. MRI of the liver: can true FISP replace HASTE?. J Magn Reson Imaging 2003, 17:190-196.
5. Numminen K., Halavaara J., Isoniemi H., et al. Magnetic resonance imaging of the liver: true fast imaging with steady state free precession sequence facilitates rapid and reliable distinction between hepatic hemangiomas and liver malignancies. J Comput Assist Tomogr 2003, 27:571-576.
6. Lauenstein T.C., Sharma P., Hughes T., et al. Evaluation of optimized inversion-recovery fat-suppression techniques for T2-weighted abdominal MR imaging. J Magn Reson Imaging 2008, 27:1448-1454.
7. Reeder S.B., Yu H., Johnson J.W., et al. T1- and T2-weighted fast spin-echo imaging of the brachial plexus and cervical spine with IDEAL water-fat separation. J Magn Reson Imaging 2006, 24:825-832.
8. Low R.N., Ma J., Panchal N. Fast spin-echo triple-echo Dixon: initial clinical experience with a novel pulse sequence for fat-suppressed T2-weighted abdominal MR imaging. J Magn Reson Imaging 2009, 30:569-577.
9. Ma J., Son J.B., Zhou Y., et al. Fast spin-echo triple-echo Dixon (fTED) technique for efficient T2-weighted water and fat imaging. Magn Reson Med 2007, 58:103-109.
10. Bayramoglu S., Kilickesmez O., Cimilli T., et al. T2-weighted MRI of the upper abdomen: comparison of four fat-suppressed T2-weighted sequences including PROPELLER (BLADE) technique. Acad Radiol 2010, 17(3):368-374. [Epub 2009 Dec 30].
11. Nanko S., Oshima H., Watanabe T., et al. Usefulness of the application of the BLADE technique to reduce motion artifacts on navigation-triggered prospective acquisition correction (PACE) T2-weighted MRI (T2WI) of the liver. J Magn Reson Imaging 2009, 30:321-326.
12. Hirokawa Y., Isoda H., Maetani Y.S., et al. Evaluation of motion correction effect and image quality with the periodically rotated overlapping parallel lines with enhanced reconstruction (PROPELLER) (BLADE) and parallel imaging acquisition technique in the upper abdomen. J Magn Reson Imaging 2008, 28:957-962.
13. Michaely H.J., Kramer H., Weckbach S., et al. Renal T2-weighted turbo-spin-echo imaging with BLADE at 3.0 tesla: initial experience. J Magn Reson Imaging 2008, 27:148-153.
14. Arizono S., Isoda H., Maetani Y.S., et al. High-spatial-resolution three-dimensional MR cholangiography using a high-sampling-efficiency technique (SPACE) at 3T: comparison with the conventional constant flip angle sequence in healthy volunteers. J Magn Reson Imaging 2008, 28:685-690.
15. Weigel M., Hennig J. Contrast behavior and relaxation effects of conventional and hyperecho-turbo spin echo sequences at 1.5 and 3 T. Magn Reson Med 2006, 55:826-835.
16. Morita S., Ueno E., Masukawa A., et al. Comparison of SPACE and 3D TSE MRCP at 1.5T focusing on difference in echo spacing. Magn Reson Med Sci 2009, 8:101-105.
17. Haystead C.M., Dale B.M., Merkle E.M. N/2 ghosting artifacts: elimination at 3.0-T MR cholangiography with SPACE pulse sequence. Radiology 2008, 246:589-595.
18. Sodickson A., Mortele K.J., Barish M.A., et al. Three-dimensional fast-recovery fast spin-echo MRCP: comparison with two-dimensional single-shot fast spin-echo techniques. Radiology 2006, 238:549-559.
19. Yoon L.S., Catalano O.A., Fritz S., et al. Another dimension in magnetic resonance cholangiopancreatography: comparison of 2- and 3-dimensional magnetic resonance cholangiopancreatography for the evaluation of intraductal papillary mucinous neoplasm of the pancreas. J Comput Assist Tomogr 2009, 33:363-368.
20. Busse R.F., Riederer S.J., Fletcher J.G., et al. Interactive fast spin-echo imaging. Magn Reson Med 2000, 44:339-348.
21. Chey W.Y., Chang T.M. Secretin, 100 years later. J Gastroenterol 2003, 38:1025-1035.
22. Motosugi U., Ichikawa T., Araki T., et al. Secretin-stimulating MRCP in patients with pancreatobiliary maljunction and occult pancreatobiliary reflux: direct demonstration of pancreatobiliary reflux. Eur Radiol 2007, 17:2262-2267.
23. Balci N.C., Alkaade S., Magas L., et al. Suspected chronic pancreatitis with normal MRCP: findings on MRI in correlation with secretin MRCP. J Magn Reson Imaging 2008, 27:125-131.
24. Czako L. Diagnosis of early-stage chronic pancreatitis by secretin-enhanced magnetic resonance cholangiopancreatography. J Gastroenterol 2007, 42(Suppl 17):113-117.
25. Sai J.K., Suyama M., Kubokawa Y., et al. Diagnosis of mild chronic pancreatitis (Cambridge classification): comparative study using secretin injection-magnetic resonance cholangiopancreatography and endoscopic retrograde pancreatography. World J Gastroenterol 2008, 14:1218-1221.
26. Sugiyama M., Haradome H., Atomi Y. Magnetic resonance imaging for diagnosing chronic pancreatitis. J.Gastroenterol 2007, 42(Suppl 17):108-112.
27. Bali M.A., Sztantics A., Metens T., et al. Quantification of pancreatic exocrine function with secretin-enhanced magnetic resonance cholangiopancreatography: normal values and short-term effects of pancreatic duct drainage procedures in chronic pancreatitis. Initial results. Eur Radiol 2005, 15:2110-2121.
28. Czako L., Endes J., Takacs T., et al. Evaluation of pancreatic exocrine function by secretin-enhanced magnetic resonance cholangiopancreatography. Pancreas 2001, 23:323-328.
29. Lee N.J., Kim K.W., Kim T.K., et al. Secretin-stimulated MRCP. Abdom Imaging 2006, 31:575-581.
30. Punwani S., Gillams A.R., Lees W.R. Non-invasive quantification of pancreatic exocrine function using secretin-stimulated MRCP. Eur Radiol 2003, 13:273-276.
31. Cappeliez O., Delhaye M., Deviere J., et al. Chronic pancreatitis: evaluation of pancreatic exocrine function with MR pancreatography after secretin stimulation. Radiology 2000, 215:358-364.
32. Hellund J.C., Skattum J., Buanes T., et al. Secretin-stimulated magnetic resonance cholangiopancreatography of patients with unclear disease in the pancreaticobiliary tract. Acta Radiol 2007, 48:135-141.
33. Ragozzino A., Manfredi R., Scaglione M., et al. The use of MRCP in the detection of pancreatic injuries after blunt trauma. Emerg Radiol 2003, 10:14-18.
34. Earls J.P., Rofsky N.M., Decorato D.R., et al. Hepatic arterial-phase dynamic gadolinium-enhanced MR imaging: optimization with a test examination and a power injector. Radiology 1997, 202:268-273.
35. Sharma P., Kitajima H.D., Kalb B., et al. Gadolinium-enhanced imaging of liver tumors and manifestations of hepatitis: pharmacodynamic and technical considerations. Top Magn Reson Imaging 2009, 20:71-78.
36. Materne R., Horsmans Y., Jamart J., et al. Gadolinium-enhanced arterial-phase MR imaging of hypervascular liver tumors: comparison between tailored and fixed scanning delays in the same patients. J Magn Reson Imaging 2000, 11:244-249.
37. Glockner J.F., Hu H.H., Stanley D.W., et al. Parallel MR imaging: a user's guide. Radiographics 2005, 25:1279-1297.
38. Pruessmann K.P. Encoding and reconstruction in parallel MRI. NMR Biomed 2006, 19:288-299.
39. Hussain S.M., Wielopolski P.A., Martin D.R. Abdominal magnetic resonance imaging at 3.0 T: problem or a promise for the future?. Top Magn Reson Imaging 2005, 16:325-335.
40. Akisik F.M., Sandrasegaran K., Aisen A.M., et al. Abdominal MR imaging at 3.0 T. Radiographics 2007, 27:1433-1444.
41. Bammer R., Schoenberg S.O. Current concepts and advances in clinical parallel magnetic resonance imaging. Top Magn Reson Imaging 2004, 15:129-158.
42. Edelman R.R., Salanitri G., Brand R., et al. Magnetic resonance imaging of the pancreas at 3.0 tesla: qualitative and quantitative comparison with 1.5 tesla. Invest Radiol 2006, 41:175-180.
43. Isoda H., Kataoka M., Maetani Y., et al. MRCP imaging at 3.0 T vs. 1.5 T: preliminary experience in healthy volunteers. J Magn Reson Imaging 2007, 25:1000-1006.
44. Kim S.Y., Byun J.H., Lee S.S., et al. Biliary tract depiction in living potential liver donors: intraindividual comparison of MR cholangiography at 3.0 and 1.5 T. Radiology 2010, 254:469-478.
45. Koelblinger C., Schima W., Weber M., et al. Gadoxate-enhanced T 1-weighted MR cholangiography: comparison of 1.5 T and 3.0 T. Rofo 2009, 181:587-592.
46. Onishi H., Kim T., Hori M., et al. MR cholangiopancreatography at 3.0 T: intraindividual comparative study with MR cholangiopancreatography at 1.5 T for clinical patients. Invest Radiol 2009, 44:559-565.
47. Ramalho M., Heredia V., Tsurusaki M., et al. Quantitative and qualitative comparison of 1.5 and 3.0 tesla MRI in patients with chronic liver diseases. J Magn Reson Imaging 2009, 29:869-879.
48. Schmidt G.P., Wintersperger B., Graser A., et al. High-resolution whole-body magnetic resonance imaging applications at 1.5 and 3 Tesla: a comparative study. Invest Radiol 2007, 42:449-459.
49. von Falkenhausen M.M., Lutterbey G., Morakkabati-Spitz N., et al. High-field-strength MR imaging of the liver at 3.0 T: intraindividual comparative study with MR imaging at 1.5 T. Radiology 2006, 241:156-166.
50. Goncalves Neto J.A., Altun E., Elazzazi M., et al. Enhancement of abdominal organs on hepatic arterial phase: quantitative comparison between 1.5- and 3.0-T magnetic resonance imaging. Magn Reson Imaging 2010, 28:47-55.
51. Lee V.S., Hecht E.M., Taouli B., et al. Body and cardiovascular MR imaging at 3.0 T. Radiology 2007, 244:692-705.